Additionally, CAV1 knockdown increased the cell surface death receptor Fas, which was also positively correlated with the PFS of bortezomib‐treated MM patients in Mulligan's cohort (Figure S3G,H, Supporting Information). Here, FAS is linked to Miyoshi myopathy.